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Protein expressionAging is accompanied by the gradual deterioration of cell functions. Particularly, mitochondrial dysfunction,
associated with an accumulation of damaged proteins, is of key importance due to the central role of these
organelles in cellular metabolism. However, the detailed molecular mechanisms involved in such impairment
have not been completely elucidated. In the present study, proteomic analyses looking at both changes at the
expression level as well as to glycative modiﬁcations of the mitochondrial proteome were performed. Two-
dimensional difference gel electrophoresis analysis revealed 16differentially expressedproteinswith aging. Thir-
teen exhibited a decreased expression and are crucial enzymes related to OXPHOS chain complex I/V
components, TCA cycle or fatty acid β-oxidation reaction. On the other hand, 2 enzymes involved in fatty acid
β-oxidation cycle were increased in aged mitochondria. Immunodetection and further identiﬁcation of glycated
proteins disclosed a set of advanced glycation endproduct-modiﬁed proteins, including 6 enzymes involved in
the fatty acid β-oxidation process, and 2 enzymes of the TCA/urea cycles. A crucial antioxidant enzyme, catalase,
was among themost strongly glycated proteins. In addition, several AGE-damaged enzymes (aldehyde dehydro-
genase 2, medium chain acyl-CoA dehydrogenase and 3-ketoacyl-CoA dehydrogenase) exhibited a decreased
activity with age. Taken together, these data suggest that liver mitochondria in old rats suffer from a decline in
their capacity for energy production, due to (i) decreased expression of OXPHOS complex I/V components and
(ii) glycative damage to key fatty acid β-oxidation and TCA/urea cycle enzymes.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Aging is an intricate phenomenon characterized by gradual
deterioration of cell functions [1,2] associated with accumulation of
damaged macromolecules, particularly proteins [3]. Several lines of
evidence suggest that mitochondria play a key role in this age-
related cellular dysfunction, as these organelles are the site of
numerous vital anabolic and catabolic pathways; that is, they play
a central role in cell metabolism [4]. ATP generation via oxidative
phosphorylation (OXPHOS) is the most prominent metabolic
process, but also their involvement in cellular signaling, including
control of apoptosis, is well established [5–7]. Malfunctions in
these metabolic and signaling reaction cascades may severely affect
cellular homeostasis, hence playing a central role during the aging
process. It is generally believed that dysfunction in mitochondriael electrophoresis; 2D-GE, two-
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ights reserved.has a causative role in aging; that is, they are triggering key steps
in this process [8–10]. Importantly, these organelles are both a
major source of intracellular reactive oxygen species (ROS) and the
most adversely affected organelles during aging [8,11]. Indeed,
studies on isolated mitochondria have shown that about 0.2% of the
total oxygen consumed is used to generate 90% of ROS in cells as
byproducts of aerobic respiration [12]. Numerous studies have
indicated an age-related increase in the rate of mitochondrial free
radical generation and in the extent of oxidative damage to
mitochondrial macromolecules [9,10,13], especially enzymes involved
in the respiratory chain, leading to impairment of respiratory activity
[13–16].
Although direct oxidation of proteins and other macromolecules is
believed to be the main type of endogenous damage during aging
[8,17,18], recent studies have revealed that mitochondria also suffer
from glycative stress [19–21], in agreement with a causal relationship
between hyperglycemia-induced ROS generation and the previously
reported intracellular advanced glycation endproduct (AGEs) formation
[22,23]. In particular, a rise in AGE formation was shown to be due to a
rapid increase in AGE-forming methylglyoxal (MGO) concentrations,
mainly generated by fragmentation of glyceraldehyde-3-phosphate (G-
3P) and dehydroxyacetone-phosphate (DHA-P) from the glycolytic path-
way [24]. Interestingly, we have recently reported that mitochondrial
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and that these altered proteins concomitantly accumulate during
rat liver aging [19], and replicative senescence of ﬁbroblasts [25].
Thus, the consequence of such a ROS-mediated attack is the accumu-
lation of oxidatively and/or glycoxidatively damaged proteins, which
may contribute to dysfunctioning of this organelle, leading in ﬁne to
impairment of cell function [19,20].
Impairment of mitochondrial protein synthesis is also prevalent in
the elderly. Studies performed on numerous organs such as skeletal
muscle in humans showed that such dysfunctioning is related to
reducedmitochondrial DNA (mtDNA) abundance, a possible underlying
cause of this dysfunctioning during the aging process [26]. However,
recent studies conducted on Rhesus monkeys showed increased levels
of mtDNA in brain [27] and skeletal muscle [28] associated with a
decreasedmitochondrialmembrane potential [29]. Decreased synthesis
of mitochondrial proteins in human skeletal muscle has been described
elsewhere and is likely contributing to the decline in mitochondrial
function [30], whereas in the heart, a number of different mechanisms
are known to be involved in decreased mitochondrial activity [31].
Reduced protein synthesis was also associated with altered activity of
oxidative metabolism enzymes in particular cytochrome c oxidase
(COX) in rat skeletal muscle, liver and heart, but appeared to be tissue-
speciﬁc [32].
Thus, a number of different mechanisms are thought to be
involved in age-related impairment in mitochondrial function, but
data documenting precise metabolic pathways affected at the
molecular level remain largely elusive. The purpose of this study
was to determine whether an age-related decline in rat liver
mitochondrial function could be linked to changes in the expression
of proteins involved in key metabolic processes, in addition to post-
translationally altered proteins, especially AGE-damaged enzymes in
liver mitochondrial matrix. We have previously shown a decreased
activity of aconitase both in heart and liver mitochondria. However,
the Lon protease activity was affected only in the liver, in parallel
with an age-related accumulation of glycation-damaged matrix
proteins with aging, indicating that this organ is early subjected to
damage in Wistar rat [19,33]. Herein, we extended our studies on
aged liver mitochondria showing that, among a set of differentially
expressed proteins, several exhibited decreased expression and
were crucial OXPHOS complex I/V components and key enzymes
implicated in the fatty acid β-oxidation process as well as in the
tricarboxylic acid (TCA) cycle. In addition, most of the fatty acid β-
oxidation enzymes appeared to be AGE-modiﬁed with a subsequent
decrease of their activities, whereas few of them exhibited both
handicaps. Altogether, these data suggest that a reduction in
expression of crucial OXPHOS complex I/V components and
increased glycative damage of key fatty acid β-oxidation and TCA/
urea cycle enzymes, thereby compromising their activity [20,34],
may be primary determinants in the age-related decline in energy
production of liver mitochondria, leading to cell dysfunction with
aging in rats.
2. Materials and methods
2.1. Chemicals
Cyanine dyes for detecting protein abundance in difference gel
electrophoresis (CyDye DIGE) ﬂuor minimal dyes Cy2, Cy3 and Cy5,
two-dimensional difference gel electrophoresis (2D-DIGE) materials
and other 2D chemicals of analytical grade, as well as Western blot
reagents, were purchased from GE Healthcare (Saclay, France).
Coomassie brilliant blue G-250, the Bradford protein assay kit and
chemicals for SDS-PAGE were purchased from Bio-Rad (Marnes La
Coquette, France). All other reagents were obtained from Sigma-
Aldrich (Saint-Quentin Fallavier, France) in the highest purity, unless
speciﬁed.2.2. Experimental protocols
Experiments were performed on femaleWistar (Wistar–RjHan) rats
purchased from Janvier animal care (Janvier, Le Genest Saint Isle,
France). Cohorts were constituted of young adults (3 months old) and
elderly (20 months old) animals. These two time-points were chosen
according to the previous study showing that mitochondria isolated
from Wistar rat heart (postmitotic cells) or liver (slowly dividing
cells), exhibited a signiﬁcant decrease in the respiratory activity (the
rate of net oxygen consumption and the state 3) from 10 month- until
27 month- compared with 3 month-old [33]. The animals were killed
by cervical dislocation and the liver was excised for preparation of
isolated mitochondria.
2.3. Isolation of liver mitochondria
Mitochondria from individual rat liverswere isolated using differen-
tial centrifugation as previously described [19] and coupledwith a Ficoll
gradient. Brieﬂy, a 10% (w/v) tissue homogenate was prepared with a
Potter apparatus in ice-cold isolation buffer containing 220 mMmanni-
tol, 70 mM sucrose, 0.1 mM EDTA and 2 mM Hepes (pH 7.4)
supplemented with 0.5% BSA (w/v). Nuclei and cellular debris were
pelleted by centrifugation for 10 min at 800 g at 4 °C. The supernatant
was centrifuged at 8000 g for 10 min at 4 °C. The mitochondrial pellet
was washed three times with homogenization medium and the last
pellet resuspended in the same buffer and submitted to a discontinuous
Ficoll gradient (10% and 7.5% from the bottom of tube) in sucrose buffer
(75 mMsucrose, 1 mMEGTAand 5 mMHepes pH 7.4) and centrifuged
at 75,000 g for 30 min. The pellet containing free mitochondria was
washed three times, resuspended in isolation buffer and contamination
of preparation with lysosomes has been estimated using acid phospha-
tase activity as a marker as previously described [20]. Mitochondrial
preparation was then stored at−80 °C.
To prepare soluble protein extract, mitochondria were resuspended
in 50 mMTris–HCl, pH 7.9, then disrupted by sonication (4 times, 10 s).
The resulting suspension was centrifuged at 15,000 g for 10 min and
then the resulting supernatant at 100,000 g for 45 min at 4 °C. The
high-speed supernatant fraction containing the soluble protein fraction
(namedmitochondrial extract) was stored at−80 °C for further analy-
sis. Total protein concentration was determined using the Bradford
protein assay (Bio-Rad, München, Germany).
2.4. 2D-gel electrophoresis and Western blot of AGE-modiﬁed proteins
Mitochondrial extract samples (150 μg) from young and aged
rats were mixed with 200 μl of two-dimensional sample buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 1% DTT, 2% Pharmalytes pH 3–
11). After rehydration of strips, isoelectrofocalization (IEF) of the
strips was performed using the IPGphor3 system (GE Healthcare).
At the end of the cycle, strips were stocked at −20 °C before the
equilibration step and then submitted to second dimension gel
electrophoresis (2D-GE) on an 8–18% (w/v) polyacrylamide SDS-
PAGE gradient in a Ettan-DALT-6 system (GE Healthcare). Two gels
were performed in parallel, one for Coomassie brillant blue staining
and the second for electroblotting onto a polyvinylidene diﬂuoride
(PVDF) membrane. After transfer, the membrane was incubated for
2 h at room temperature in blocking solution and Western blot was
performed using an anti-AGE monoclonal antibody (clone 6D12), as
previously described [20]. The proteinswere revealedwith a SuperSignal
West Pico chemiluminescent reagent (Perbio Science Company,
Brebières, France) and densitometry analyses were performed using
Image Master 2D Platinum 7 software (GE Healthcare). Colloidal
Coomassie blue-stained spots matched with bands immunolabelled
with anti-AGE antibodies were excised from the gel and submitted to
mass spectrometry analysis as indicated below.
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For each spot identiﬁed by Coomassie blue as well as from the
Western blot a percentage volume was obtained in pixel (%vol)
using the Image Master 2D Platinum 7 software. The %vol corre-
sponds to a normalized value of the spot volume by considering the
total volume of all the spots present in the gels or on ﬁlms. %vol of
glycated spots from old and young rats was normalized to %vol of
the corresponding Coomassie-stained spot to obtain a normalized
%vol (N%Vol). The N%vol of old rats was divided by the N%vol of
young rats to obtain the relative modiﬁcation index ratio (RMI
ratio). Spots with an RMI ratio ≥1.3 (p ≤ 5%) were considered
signiﬁcantly glycated with age.2.5. Protein labeling and expression proﬁling using 2D-DIGE
Mitochondrial extract samples (50 μg) were labeled with CyDyes
DIGE ﬂuor minimal dyes (kit GE Healthcare) either with Cy3 and Cy5
for young and aged rats respectively. An internal standard containing
a pool of equal amounts of protein from each sample and labeled with
Cy2 was included. For analytical gels, 18-cm immobilized non-linear
(NL) pH gradient gels (pH 3–11) were loaded with 150 μg of mixed
labeled proteins (50 μg from young and aged rats and 50 μg of internal
standard). For preparative gels, 400 μg of pooled young (n = 4) or
pooled aged (n = 4) unlabeled matrix proteins were used. After rehy-
dration of strips, isoelectrofocalization of the different strips was
performed using the IPGphor3 system (GE Healthcare). At the end of
the cycle, strips were stocked at −20 °C before the equilibration step.
Equilibrated strips were applied to homemade gradient an Ettan-
DALT-6 system (GE Healthcare). Four analytical and two preparative
gels were run in parallel. Analytical gels were imaged using an Ettan
DIGE Imager (GE Healthcare) scanner. Datasets from young (n = 4)
and aged (n = 4) samples collected with the DeCyder 7.0 extended
data analysis package were analyzed separately for improving the
detection of differentially expressed proteins. The unpaired Student's t
test (p b 5%) was used to analyze statistical differences in the mean
ratio in protein spot intensity, with a threshold set at least 1.5-fold
change. Unlabeled preparative gels were ﬁxed and stained with
Coomassie brilliant blue. Matching of spots of interest between analyti-
cal and preparative gels was performed manually.2.6. Spot selection and mass spectrometry protein identiﬁcation
All spots considered by the software as signiﬁcantly regulated
were visually checked, selected and a pick list was created. We
thereby selected 20 protein spots that were differentially expressed
with aging. These spots of interest were manually excised on
Coomassie blue gel by visual comparison with the 2D-DIGE master
gel and sent for analysis by the mass spectrometry facility (3P5
roteomic facility, Université Paris Descartes, Sorbonne Paris Cité).
Brieﬂy, tryptic in-gel digestion was performed as described by
Shevchenko et al. with minor modiﬁcations [35] and automated
with a freedom EVO 100 digester/spotter robot (Tecan, Mannedorf,
Switzerland). After digestion and desalting, eluates were dried and
samples were analyzed by a MALDI-TOF-TOF 4800 mass spectrome-
ter (ABSciex, Foster City, CA, USA). Database searching was carried
out using Mascot version 2.2 (MatrixScience, London, UK) via GPS
explorer software (ABI) version 3.6 combining MS and MS/MS
interrogations on rattus protein from the Swiss-Prot databank,
7620 entries (Swiss-Prot databank: 5280 sequences; 186,939,477
residues, www.expasy.org). A number of different spots had the
same protein identity, indicating the existence of post-translational
modiﬁcations. We identiﬁed 16 proteins, their theoretical and
experimental MW/pI, together with the fold change in their expres-
sion ratio between aged and young rats.2.7. Assessment of mitochondrial enzymes activities (ALDH2, MCAD and
THIM), effect of glycating agent MGO
Mitochondrial aldehyde dehydrogenase (ALDH2) activity was
measured by increased production of NADH at 340 nm by the method
of Tank et al. [36], using a Uvikon 922 spectrophotometer (Kontron
Instrument, Neufahrn, Germany). The reaction mixture contained
60 mM Na-phosphate buffer (pH 8.5), 1 mM NAD+, 1 mM EDTA and
mitochondrial proteins (500 μg/assay). After the reaction mixture was
kept for 1 min at room temperature, the enzyme reaction was initiated
by adding the substrate (10 μM propionaldehyde) and the absorbance
change was monitored for 2 min to calculate the rat of NADH produc-
tion. Speciﬁc activity was calculated by using εM340nm of reduced NAD
of 6.22 mM cm−1 and expressed as nmol NAD+/min/mg protein. All
assays were performed in triplicate.
The activity of medium-chain acyl-CoA dehydrogenase (MCAD) was
assayed following the decrease in absorbance at 600 nm using phena-
zine methosulfate (PMS) and 2.6-dichlorophenolindophenol (DCPIP) as
intermediate and terminal electron acceptors respectively (εM600nm =
21 mM−1 cm−1) according to Zeng J et al. [37]. The assay mixture
contained 33 μM octanoyl-CoA, 1.5 mM PMS, 48 μM DCPIP in 50 mM
potassium phosphate buffer pH 7.6. The ﬁnal volume was 1 ml and the
reaction was started by adding 250 μg mitochondrial protein extract
and curve recorded for 1 min.
The activity of 3-ketoacyl-CoA thiolase (THIM) was determined
through thiolytic cleavage of acetoacetyl-CoA following the decrease in
absorbance at 303 nm due to the disappearance of the Mg2+-enolate
complexe of acetoacetyl-CoA (εM303nm = 16,5 mM−1 cm−1) according
to Liu et al. [38]. The assay mixture contained 100 mM Tris–HCl
(pH 8.0), 25 mM MgCl2, 40 μM acetoacetyl-CoA, 90 μM CoASH and the
reaction was started by adding 250 μg of the mitochondrial protein
extract. Unit of speciﬁc thiolase activity was deﬁned as the amount of
thiolase that catalyzes the cleavage of 1 μmol acetoacetyl-CoA/min/mg.
To analyze the impact of glycation on enzyme activities,mitochondrial
protein extracts from young (3-month-old rats) were incubated with
1 mM MGO up to 5 h and the activity was assayed for every enzyme as
described above and reported as speciﬁc activity. Activity was then
expressed relative to the control activity at each incubation time, set at
100%.
2.8. In silico analyses
Functional pathway and network analyses were generated using the
Ingenuity pathway analysis software (version 2.0, Ingenuity Systems,
Mountain View, CA, USA), as described previously [39]. Ingenuity path-
way analysis identiﬁed those canonical pathways, biological processes,
and gene interaction networks that were most signiﬁcant for the
glycated and differentially expressed proteins identiﬁed in aged rat
liver mitochondria. Each protein designation was mapped in the
Ingenuity Pathways Knowledge Base.
2.9. Statistical analysis
Results are presented as means ± SEM, and differences between
groups were assessed by Student's unpaired t-test. Signiﬁcance was
set at p ≤ 5%.
3. Results
3.1. Changes in the mitochondrial proteome with aging
3.1.1. Identiﬁcation of mitochondrial proteins differentially expressed with
aging
To better understand the molecular mechanisms underlying mi-
tochondrial dysfunction with aging, a proteomic 2D-DIGE and mass
spectrometry (MS) based approach was used. Mitochondrial protein
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Cy3, respectively to enable all comparisons and eliminate any dye-
labeling bias, while equal amounts of proteins from all analyzed sam-
ples were pooled together as an internal standard and labeled with
Cy2. The incorporation of this internal standard on each gel has been re-
ported to improve the accuracy of spot matching and the reliability of
the quantitative comparison of the spots between gels. The normalized
ratio of the protein expression level for each spotwas calculated relative
to the internal standard, and inter-gel spot matching was performed
using the DeCyder software. Samples from four biological replicates
from young or old animals were analyzed in parallel in four different
gels. After 2D-DIGE the ﬂuorescent images were obtained (Fig. 1) and
analyzed. Proteinswere resolved in all areas of the gelwithout streaking
and more than 3000 spots were matched for each condition. Although
in a preliminary analysis more than 37 differentially expressed spots
were observed, 20 reached the statistically signiﬁcant threshold
(p ≤ 5%) established. As depicted in Fig. 2, a principal analysis biplot
of the selected spots showed a distinct clustering of the old (red
squares) compared to the young (black squares) samples, indicating
thatDIGE-based proteomic analysis is an appropriatemethod for study-
ing differentially expressed mitochondrial soluble proteins during
aging. Quantitative differences in both individual and full trail variations
in these 20 spot intensities of labeling were observed at the two ages
studied, indicating up- or down-regulation of expression of mitochon-
drial proteins. According to the established threshold (1.3 ≥ fold; Stu-
dent's t-test, p ≤ 5%), a total of 20 spots exhibited differences in
normalized spot volume ratios. At least two spots for each trail of
isoforms were identiﬁed with sufﬁcient peptide coverage (11–44%)
(Table 1). The number of peptides leading to identiﬁcation of each pro-
tein varied between 4 and 12. Further analysis of the 20 spots led to
identiﬁcation of 16 different proteins in a narrow pI range (5.2–9.4)
with a molecularmass in the range of 25–130 kDa. Among these differ-
entially expressed proteins, most (17 spots) exhibited decreased ex-
pression with aging. Among these, 6 different identiﬁed proteins
belong to the oxidoreductase family of enzymes implicated in the TCA


















Fig. 1. Representative 2D-DIGE gel images of livermitochondrial matrix protein with aging.
After being labeled with CyDyes, 50 μg of mitochondrial matrix extracts were
electrofocused and then separated on gradient acrylamide SDS-PAGE and scanned at conve-
nient wave lengths (Cy2 λEx480/λEm 530, Cy3 λEx 540/λEm595, Cy5 λEx635/λEm680). A1
(Cy2): Internal standard; A2 (Cy3) and A3 (Cy5): proteins from young and old samples,
respectively. B: Combined protein proﬁle of internal standard, young and old samples
(green spot: protein up-expressed in young sample; red spot: protein up-expressed in old
sample; yellow spot: unchanged expression).apart from its role in gluconeogenesis (spot 1)], fatty acid metabolism/
β-oxidation [D-β-hydroxybutyrate dehydrogenase (spot 17), medium-
and long-chain speciﬁc acyl-CoA dehydrogenase (spots 8,10), α-
methylacyl-CoA racemase (spots 11,12,13)]; and also in leucine catabo-
lism [isovaleryl-CoA dehydrogenase (spot 7)]. Of particular interest was
the decreased expression of the oxidative phosphorylation complex pro-
teins: the complex I subunit [NADPH: adrenodoxin oxidoreductase, an es-
sential component of the electron transport system (spot 4)] and the
complex V subunit [the ATP synthase β subunit (spot 2)] and also, a
spot corresponding to a urea cycle enzyme [ornithine aminotransferase
(spot 6)]. Finally both hydroxyacid oxidase 1 and 2 also referred to as
glycolate oxidase were the most down regulated enzymes.
Three spots exhibiting increased expression include two fatty acidβ-
oxidative enzymes [the hydroxyacyl-CoA dehydrogenase (spot 18) and
the enoyl-CoA hydratase (spot 19)], in addition to the antioxidant
enzyme manganese superoxide dismutase (Mn-SOD) (spot 20).
3.1.2. Identiﬁcation of glycated mitochondrial proteins with aging
3.1.2.1. Western blot analysis of AGE-modiﬁed proteins. Although aging as
well as certain pathological conditions are characterized by increased
oxidative stress leading to the accumulation of damaged macromole-
cules, the proteins targeted by these modiﬁcations have not yet been
identiﬁed in most cases. The identiﬁcation of these targets may give
insights into the mechanisms by which these damaged proteins could
affect cellular functions.
Western blot analysis using anti-AGE speciﬁc antibodies to
carboxymethyl- and carboxyethyl-lysine (CML/CEL) after 2D-GE sepa-
ration revealed that most anionic isoforms in trails of spots observed
in the DIGE experiment are indeed AGE-modiﬁed (Fig. 4). Although
some of these spots were also evidenced at a young age (Fig. 4A),
most spots exhibited increased immunoreactivity to anti-AGE antibod-
ies with advancing age (Fig. 4B). Interestingly, spot trails were observed
only in aged samples. Spots that exhibited a signiﬁcantly increased yield
of labelingwith aging (ratio ≥ 1.3 p ≤ 5%)were retained and subjected
to protein identiﬁcation bymass spectrometry after matching with col-
loidal Coomassie blue staining spots (Fig. 5). Standard 2D-GE of liver
mitochondrial extract samples from young and old rats was run in par-
allel on a gradient gel (Fig. 3). Coomassie blue-stained spots exhibited
individual variations in the extent of labeling, and more than three
thousands spots were detected using 2D Elite master Software.
At least two spots from each trail were identiﬁed, leading to 16
different proteins (Table 2). Of note, 6 enzymes involved in mito-
chondrial fatty acid ß-oxidation were observed as increasingly
glycated in aged liver mitochondria: 1) medium/long-chain speciﬁc
acyl-CoA dehydrogenase (MCAD) (spots 5, 6), which catalyzes the
initial step of the cycle and whose expression levels already
appeared to be down-expressed (Table 1, spots numbered 8, 10);
2) 3-ketoacyl-CoA thiolase (THIM), one of the mitochondrial
trifunctional protein (MTP) α subunit catalyzing the β-oxidation
steps of long-chain fatty acids (spots 12, 14, 15); 3) enoyl-CoA
hydratase second member of the MTP α subunit, catalyzes the
second step in β-oxidation [syn addition of water across the double
bond of α, β-unsaturated thiol esters (spots 28, 29)]; 4) enoyl-CoA
δ-isomerase 1, which catalyzes transformation of 3-cis and 3-trans-
enoyl-CoA esters arising during stepwise degradation of cis-,
mono-, and poly-unsaturated fatty acids to the 2-trans-enoyl-CoA
intermediates (spot 30); 5) hydroxyacyl-CoA dehydrogenase the
third enzyme of MTPα subunit, involved in the third step of ß-oxida-
tion that converts the hydroxyl group into a keto group (spots 21, 22,
23, 24); and 6) acetyl-CoA acetyltransferase [β-ketothiolase], which
participates in the ﬁnal step of ß-oxidation (cleavage of 3-ketoacyl-
CoA by the thiol group of another molecule of CoA) (spot 17).
A second group of proteins identiﬁed as increasingly modiﬁed in
aged liver mitochondria, were 4 oxidoreductase enzymes implicated
in TCA and urea cycles: glutamate dehydrogenase at the interface
Fig. 2. 2D-DIGEmultivariate data analysis. Principal component analysis (PCA) loading and score plots showing the clustering of the eight individual Cy3- and Cy5-labeled DIGE spotmaps
and the subset of proteins with intensity labeling ratio of≥1.3 (p b 5%) in the two components. The PCA reduces the dimensionality of themultidimensional analysis and display the two
principal components that distinguish the largest sources of variation within the dataset. The datasets from the four replicates (proteins from old and young samples) were grouped to-
gether with the ﬁrst component (PC1) in the loading plot.
Table 1
Protein identiﬁcation of 2D-DIGE-identiﬁed differentially expressed spots in liver mitochondrial matrix with aging. Spots of interest (ratio ≥ 1.3) were identiﬁed byMALDI-TOF/TOF-MS




















PYC_RAT −1.94 0.059 Pyruvate carboxylase 674 14 11 11.0 6
DIGE
02
ATPB_RAT −1.49 0.006 ATP synthase subunit beta 528 12 41 5.2 56
DIGE
03
gi 56605722 −1.72 0.045 serine hydroxymethyltransferase 247 6 22 8.5 56
DIGE
04
ADRO_RAT −1.68 0.009 NADPH: adrenodoxin oxidoreductase 109 4 26 9.4 54
DIGE
05
SUOX_RAT −1.65 0.027 Sulﬁte oxidase 82 3 10 6.4 61
DIGE
06
QAT_RAT −1.65 0.027 Ornithine aminotransferase 187 7 22 6.5 48
DIGE
07
IVD_RAT −1.48 0.016 Isovalerly-CoA dehydrogenase 130 4 20 8.0 46
DIGE
08
ACADL_RAT −1.45 0.021 Long-chain speciﬁc acyl-CoA dehydrogenase 422 9 36 7.6 48
DIGE
09
ACADM_RAT −2.25 0.024 Medium-chain speciﬁc acyl-CoA
dehydrogenase
664 10 31 8.6 47
DIGE
10
ACADM_RAT –1.80 0.020 Medium-chain speciﬁc acyl-CoA
dehydrogenase
486 9 29 8.6 47
DIGE
11
AMACR_RAT −1.67 0.010 Alpha-methylacyl-CoA racemase 175 4 21 6.4 42
DIGE
12
AMACR_RAT −1.72 0.021 Alpha-methylacyl-CoA racemase 385 6 30 6.4 42
DIGE
13
AMACR_RAT −1.72 0.034 Alpha-methylacyl-CoA racemase 122 3 8 6.4 42
DIGE
14
gi 157821243 −2.51 0.014 Hydroxyacid oxidase 1 481 8 44 6.9 41
DIGE
15
HAOX2_RAT −5.22 0.005 Hydroxyacid oxidase 2 312 6 26 7.6 39
DIGE
16
BHMTI_RAT −1.54 0.015 Betaine-homocysteine S-methyltransferase 1 92 2 4 8.0 45
DIGE
17




HCDH_RAT 2.13 0.020 Hydroxyacyl-coenzyme A dehydrogenase 31 1 2 8.8 34
DIGE
19
ECHM_RAT 1.45 0.018 Enoyl-CoA hydratase 83 2 2 7.2 32
DIGE
20
SODM_RAT 1.31 0.034 Superoxide dismutase [Mn] 278 5 34 9.0 25
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Fig. 3. Coomassie blue staining of 2D-DIGE preparative gel. CyDyes-labeled samples
(400 μg) were electrofocused, separated on 2D-gradient SDS-PAGE and then stained
with colloidal Coomassie blue. The numbers and positions of 36 selected spots located
on the gel (≥1.3-fold change) for differentially expressed spots were used for identiﬁca-
tion by MALDI-TOF/TOF-MS.
Fig. 5. Matching of 2D-DIGE Coomassie blue-stained gel and Western blot of AGE-modi-
ﬁed proteins. Labeled proteins (Cy5) from old samples (150 μg) were subjected to 2D-
gel electrophoresis and submitted to either Coomassie blue staining or Western blotting
using mAb anti-AGE. Selected spots of interest (labeling intensity ≥ 1.3-fold, Fig. 4)
were matched with master gel. The numbers and positions of 31 spots refer to numbered
spots from both Fig. 3 (numbered in blue) and Fig. 4 (numbered in red).
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which catalyzes oxidation of malate to oxaloacetate in the TCA cycle
(spots 25, 26, 27), ornithine carbamoyltransferase, involved in the
urea cycle (spot 19) and aspartate aminotransferase, an important
enzyme in amino acid metabolism linked to the urea and TCA cycles
(spot 18).
A third group is constituted of metabolic enzymes: 4-hydroxy-2-
oxoglutarate, aldolase that belongs to the family of lyases, especially
oxo-acid-lyase, which cleaves carbon–carbon bonds (spot 20),
hydroxymethylglutaryl-CoA synthase, belonging to the family ofFig. 4. 2D-gel electrophoresis and western blotting: identiﬁcation of AGE-modiﬁed proteins in l
subsequent linear gradient SDS-PAGE under reducing conditions. Gels were then subjected toW
young (A) or old (B) rats. The numbers and positions of 36 selected spots matched with maste
from old samples (Fig. 5) for identiﬁcation by MALDI TOF/TOF-MS.transferases, which catalyzes the reaction in which acyl-CoA
condenses with acetoacyl-CoA (ketogenesis) (spots 9, 10, 11), aldehyde
dehydrogenase-2 (ALDH2), a NADP-dependent enzyme whose estab-
lished function is the oxidative detoxiﬁcation of ethanol-derived acetal-
dehyde but also essential for bioconversion of glyceryl trinitrate
(GTN) so involved in GTN-induced vascular relaxation (spots 7, 8) and
glutaryl-CoA dehydrogenase, involved in the degradative pathway of
lysine (spot 13).iver mitochondrial matrix with aging. Samples (150 μg) were subjected to isofocusing and
estern blot analysis usingmAb anti-AGE to detect AGE-modiﬁed proteins in samples from
r gel spots (2D-DIGE Coomassie blue gel) (labeling intensity ≥ 1.3 folds) were picked up
Table 2
Identiﬁcation of glycation-modiﬁed livermitochondrialmatrix proteinswith aging. 2D-GE samples fromyoung and old ratswere subjected toWestern blotting usingmAbanti-AGE (clone
6D12). Selected spots with RMI ≥ 1.3 (p ≤ 5%)were identiﬁed byMALDI-TOF/TOF-MS. The number and position of 31 selected spots refer to the numbered spots in Fig. 5. RMI represents
the relative modiﬁcation index ratio calculated as described under Materials and methods.
Spot no. Swiss-Prot no. RMI (O/Y) Protein name Total ion score No. of peptides id. Coverage % Theoretical IP Theoretical MW(kda)
AGE 01 CATA_RAT 2.3 Catalase 961 13 33 7.1 60
AGE 02 DHE3_RAT 1.9 Glutamate dehydrogenase 1 343 5 11 8.1 61
AGE 03 DHE3_RAT 3.2 Glutamate dehydrogenase 1 474 6 13 8.1 61
AGE 04 DHE3_RAT 1.5 Glutamate dehydrogenase 1 505 8 18 8.1 61
AGE 05 ACADM_RAT 1.7 Medium-chain speciﬁc acyl-CoA dehydrogenas 486 9 29 8.6 47
AGE 06 ACADL_RAT 1.5 Long-chain speciﬁc acyl-CoA dehydrogenase 422 9 36 7.6 48
AGE 07 ALDH2_RAT 1.5 Aldehyde dehydrogenase 417 9 20 6.6 56
AGE 08 ALDH2_RAT 1.3 Aldehyde dehydrogenase 493 10 22 6.6 56
AGE 09 HMCS2_RAT 1.5 Hydroxymethyglutaryl-CoA synthase 203 4 7 8.9 57
AGE 10 HMCS2_RAT 1.6 Hydroxymethyglutaryl-CoA synthase 216 4 6 8.9 57
AGE 11 HMCS2_RAT 2.4 Hydroxymethyglutaryl-CoA synthase 618 8 21 8.9 57
AGE 12 THIM_RAT 1.4 3-Ketoacyl-CoA thiolase 645 11 36 8.1 42
AGE 13 gi 157820807 2.3 Glutaryl-CoA dehydrogenase 545 9 29 9.0 50
AGE 14 THIM_RAT 1.5 3-Ketoacyl-CoA thiolase 992 12 41 8.1 42
AGE 15 THIM_RAT 1.4 3-Ketoacyl-CoA thiolase 925 12 41 8.1 42
AGE 16 gi 62078737 1.5 Aminomethyltransferase 137 3 8 9.1 44
AGE 17 THIL_RAT 1.6 Acetyl-CoA acetyltransferase 310 4 11 8.9 45
AGE 18 AATM_RAT 7.1 Aspartate aminotrasferase 634 8 21 9.1 47
AGE 19 OTC_RAT 1.4 Ornithine carbamoyltransferase 601 8 33 9.1 40
AGE 20 gi 157822207 1.5 Probable 4hydroxy-2-oxoglutarate aldolase 427 5 22 8.5 34
AGE 21 HCDH_RAT 1.8 Hydroxyacyl-coenzyme A dehydrogenase 30 1 2 8.8 34
AGE 22 HCDH_RAT 1.8 Hydroxyacyl-coenzyme A dehydrogenase 201 5 20 8.8 34
AGE 23 HCDH_RAT 2.7 Hydroxyacyl-coezyme A dehydrogenase 38 1 2 8.8 34
AGE 24 HCDH_RAT 1.5 Hydroxyacyl-coenzyme A dehydrogenase 290 6 24 8.8 34
AGE 25 MDHM_RAT 1.3 Malate dehydrogenase 610 10 40 8.9 36
AGE 26 MDHM_RAT 1.6 Malate dehydrogenase 909 11 46 8.9 36
AGE 27 MDHM_RAT 1.6 Malate dehydrogenase 1046 11 46 8.9 36
AGE 28 ECHM_RAT 1.6 Enoyl-CoA hydratase 414 6 27 8.4 31
AGE 29 ECHM_RAT 1.4 Enoyl-CoA hydratase 612 7 32 8.4 31
AGE 30 ECH_RAT 1.3 Enoyl-CoA hydratase 1 651 8 30 9.6 32
AGE 31 HMCS2_RAT 1.5 Hydroxymethylgutaryl-CoA synthase 490 7 17 8.9 57
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heavily modiﬁed (spot 1).3.2.1. Age-related changes in ALDH2, MCAD and THIM enzyme activities,
effect of MGO
3.2.1.1. Measurement of ALDH2, MCAD and THIM enzyme activities. To
assess whether increased glycation impacts on enzyme function, the
speciﬁc activities of ALDH2, MCAD and THIM were measured in rat
liver mitochondrial extracts from young and old rats. Enzyme activities
involved in two different metabolic pathways, such as the ALDH2
(implicated in detoxifying aldehyde by-products), MCAD and
THIM (both occupying a pivotal place in the fatty acid β-oxidation
cycle) were measured (Table 3). The results revealed a signiﬁcant
decrease with aging in all three activities assessed: ALDH2 activity,
varied from 8.33 ± 1.101 nmol/min/mg prot in 3-month-old rat
(n = 5) to 4.63 ± 0.45 nmol/min/mg prot in 20-month-old rats
(n = 3) (p ≤ 5%) (Fig 3A) whereas the MCAD activity varied from
5.238 ± 1.017 μmol/min/mg prot in 3-month- (n = 4) to 2.079 ±Table 3
Age-related changes in ALDH2, MCAD and THIM enzymatic activities. Enzymatic activities
were assessed on mitochondrial protein extract (total protein) from young (3 months)
and old (20 months) rats. Values are expressed as speciﬁc activity (10−x mol/min/mg)
and data represent the mean ± SEM (n = number of animals). t-test: ⁎p ≤ 5%,
⁎⁎p b 1% old- versus young-rats.
Age 3 months (n = 5) 20 months (n = 3)
Speciﬁc activity
A ALDH2 (μ mol/min/mg) 8.33 ± 1.101 4.63 ± 0.45⁎
B MCAD (nmol/min/mg) 5.238 ± 1.017 2.079 ± 0.342⁎
C THIM (nmol/min/mg) 0.164 ± 0.015 0.099 ± 0.0155⁎⁎0.342 μmol/min/mg Prot in 20-month-old rats (n = 3) (p ≤ 5%)
(Table 3-B) and the THIM activity varied from 0.164 ± 0.015 mmol/
min/mg prot (n = 5) in 3-month-, to 0.099 ± 0.014 mmol/min/mg
prot in 20-month-old rats (n = 3) (p b 5%) (Table 3-C).
3.2.1.2. Ex-vivo inhibition of ALDH2, MCAD and THIM by the glycating
agent MGO. To assess the contribution of glycation to the impairment
of enzyme activities during aging, mitochondrial protein extracts from
young (3-month-old) rats were incubated with 1 mM MGO for up to
5 h at 24 °C (Fig. 6). Previous studies have shown that this concentra-
tion was the most efﬁcient to induce glycative inhibition of enzyme
during a short time [20].
The ALDH2 activity measured in samples signiﬁcantly decreased by
60% as soon as 1 h incubation (n = 5) (p ≤ 5%) andmarkedly dropped
within 5 h incubation, barely representing 32% of the control (p b 1%).
The MCAD activity remained stable after 1 h incubation (88% of control
activity) and tended to decrease after 5 h, though ﬁnally no signiﬁcant
difference was observed.
On the other hand the THIM activity signiﬁcantly decreased by 70%
within 1 h (n = 4) (p b 1%) and barely represented 10% after 5 h incu-
bation (n = 4) (p b 1%).
The incubation of mitochondrial extracts from young rats with
glycating agent MGO (1 mM) showed a clear inhibitory effect on these
enzymes.
3.4. Cellular network analysis of differentially expressed or glycated
proteins
To get further insights into the cellular pathways potentially affected
by the glycated (Fig. 7A) or the differentially under-expressed (Fig. 7B)
mitochondrial proteins with aging, a network analysis using Ingenuity
Pathways Analysis software (version 2.0, Ingenuity Systems) was
performed. Each case appeared mainly linked to at least 2 different
Fig. 6. Effect of glycating agentMGO on ALDH2,MCAD and THIM activities. Enzymatic activities in liver mitochondrial extracts from young rats were assessed after incubationwith 1 mM
MGO up to 5 h at 24 °C. Values are expressed as percentage of control in absence of MGO. Data represent themean ± SEM (n = 4); *p ≤ 5%; **p b 1%; ***p ≤ 1% glycating agent versus
control at each incubating time.
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proteins that were mostly involved in fatty acid ß-oxidation pathway
showed the insulin receptor gene (INSR) as the central node. INSR is
the gene coding for the insulin receptor (IR, INSR, CD220), a member
of the tyrosine kinase family of receptors which mediate the effect of
insulin and IGF-1 (insulin like-growth factor-1). The pathway analysis
performed for the differentially expressed proteins depicted in Fig. 7B
exhibited a network with peroxisome proliferator-activated receptor
gamma (PPARγ) as a central node. PPARγ is a member of the PPAR
sub-family of nuclear hormone receptors known as themaster regulator
of adipogenesis, lipid metabolism and insulin sensitivity. These results
suggest that protein glycationmost importantly targets speciﬁc proteins
that are associated with key cellular pathways involved in the genera-
tion of the aged phenotype.Fig. 7. Cellular pathway analysis. Networks were obtained using Ingenuity Pathway for glycate
spond to some of the proteins identiﬁed byMALDI-TOF/TOF-MS as increasingly glycated or diffe
analysis, but associatedwith the regulation of some of the proteins identiﬁed. Information abou
able at the Ingenuity Pathway Analysis website. A line denotes binding of proteins, whereas a4. Discussion
Mitochondrial dysfunction associated with gradual deterioration of
cell functions is a hallmark of the agingprocess in several organ systems,
particularly in the liver [40,41]. However the molecular mechanisms
involved in this age-related decrease in mitochondrial activity remains
elusive. In this study we performed a dual mitochondrial proteomic
approach, looking at proteins differentially expressed but also identify-
ing those proteins damaged by glycation during rat liver aging.
Alterations in the mitochondrial protein proﬁle associated with
AGE-modiﬁed enzymes were observed with aging. Strikingly reduced
expression of several enzymes involved in key metabolic processes
were observed, such as crucial proteins implicated in OXPHOS chain
complexes I/V. Thus, we noted a decreased level of the ATP synthase βd proteins (A) and of proteins differentially expressed (B). Proteins in red and blue corre-
rentially expressed, respectively.White open nodes indicate proteins not identiﬁed in this
t the analysis of biological functions and pathways as well as network interactions is avail-
line with an arrow denotes “acts on”. A dotted line denotes an indirect interaction.
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related to a declining capacity for ATP production. In addition,
reduced levels of NADPH: adrenodoxin oxidoreductase, an essential
component in the electron transport chain (ETC) whichmay strongly
limit the electron transfer process. The electron ﬂux and hence ATP
synthesis would be particularly affected, which restricts complex I
activity, although the defect in complex 1 might be compensated
for by relying on entry at complex II as shown by studies on isolated
mitochondria [42]. In fact, the steady-state activities of the two
complexes are linked in intact cells, since the supply of succinate
via the TCA cycle is dependent on NADH-linked dehydrogenases in
the cycle. As reported in a previous study [16], while respiratory
activity and some mitochondrial carriers are impaired upon aging
in rat liver, complex I appeared to be the most strongly affected,
thereby severely hampering electron transfer. Indeed, complex I is
one of the two major respiratory chain regions and is presumably
the rate-limiting step in aerobic NADH oxidation in the elderly,
since thermodynamic as well as kinetic reactions indicated that it
may have major control over electron ﬂux from NADH to oxygen
[43]. These results suggest that the down expression of both proteins
will ultimately reduce the ability of liver mitochondria to perform
oxidative phosphorylation in old animals, in agreement with a
previous study that demonstrated that rates of both mitochondrial
oxidative and phosphorylation activity were reduced by 40% in mus-
cle and liver tissues in the elderly [41]. Indeed, most biochemical
studies of animal mitochondrial activity indicate a decline in ETC
activity with age whatever the study, and whether analyzing the en-
zymatic activity of the complete mitochondrial respiratory chain or
the rate of ADP-stimulated molecular oxygen consumption (i.e.
state 3 respiration) [20,40,44–46].
Although few enzymes implicated in the TCA cycle are affected, a
decrease in levels of an important enzyme, pyruvate carboxylase
(PC), could impair the functioning of the cycle. Aside from the prima-
ry role of PC in gluconeogenesis in the liver, PC serves an anaplerotic
purpose in the TCA cycle, essential for providing oxaloacetate; a
deﬁciency in PC can cause lactic acidosis as a result of lactate build-
up [47]. This in ﬁne should contribute to adversely affecting ATP
production capacity: since hepatocytes utilize glucose as one of the
two main energy sources, it follows that the effective functioning of
the TCA cycle is essential. Thus, most of these enzymes were down
expressed, possibly indicating a general alteration in mechanisms
involved in the TCA cycle and the OXPHOS chain, affecting the energy
production. In addition as indicated by the pathway analysis, most of
these down-expressed proteins are involved in a network with
PPARγ as a key node, known as the master regulator of adipogenesis
and glucose homeostasis [48]. Hence the alteration of PPARγ ligands
metabolism will result in the metabolic abnormalities associated
with lipometabolism, insulin resistance and type 2 diabetes disorder.
Remarkably, recent data have shown that aging alters PPARγ activity
in rodent and human tissues, triggering lipid accumulation and
insulin resistance [49]. Moreover, PPARγ cross-talks with growth
factors (TGF-ß, PDGF, HGF) [50] and also modulates cellular
senescence involved in pathology of various chronic liver diseases
[51]. Thus the dysfunction of PPARγ pathway due to altered ligand
metabolism such as fatty acids should alter numerous metabolic
pathways converging on energy production impairment. In addition,
given that PPARγ is a critical regulator in metabolic syndrome (e.g.
obesity, type 2 diabetes), it is interesting to speculate that PPARγ
has interactions with the insulin pathway in hepatic cells since the
liver is an insulin sensitive organ that plays a critical role in regulat-
ing glucose homeostasis.
Along with decreased levels, other mitochondrial proteins also
appeared increasingly glycated in aged liver mitochondria. Fatty acid
catabolism might be affected through an AGE alteration of the four sets
of enzymes of the fatty acid β-oxidation cycle, especially long/medium
chain-speciﬁc acyl-CoA dehydrogenase involved in the ﬁrst and rate-limiting step reaction, also showed decreased expression; and on
the other hand the 3-ketoacyl-CoA thiolase member of the mito-
chondrial trifunctional protein (MTP) α subunit catalyzing the last
step of the cycle. The activities of both enzymes present a signiﬁcant
decrease with age as well as that of the third enzyme, the aldehyde
dehydrogenase2. The enzymatic activities subsequently measured
in young mitochondrial extracts treated with glycating agent MGO,
evidenced a net time-dependent decline activity. This suggested an
implication of the glycative modiﬁcation in the age-related inhibi-
tion of these enzymes. Indeed as recently reported, these enzymes
possess critical amino acid residues for their catalytic activity,
Cys302 and Arg475 in ALDH2 activity [52], Cys125 and Cys403 in 3-
ketoacyl-CoA thiolase [53] and Arg256 in MCAD [54] all modiﬁable
by various agents such as 4-hydroxy-2-nonenal (4-HNE) or MGO,
resulting in their inactivation. Although it remains to be determined,
if an increase in glycolysis exists as a compensatory mechanism, this
would be also a potential source of endogenousmolecular toxicity. In-
deed, persistent glycolysis could provide a source of glycating agents
and ROS generation [22,24,54,55], amplifying the glycative- and
oxidative-stress. Importantly, the crucial antioxidant ystem enzyme
catalase, appeared markedly glycated in aged mitochondria. Previous
studies have shown the inactivation of this crucial enzymeupon glycation
[34,56]. Moreover, glycation-damage altered a crucial TCA-cycle enzyme
the glutamate dehydrogenase, suggesting that damage to this enzyme
would lead to disturbed functioning of the cycle since we and others
had previously shown an age-related decrease in the activity of these
enzymes due to post-translational modiﬁcations by glycation [20,21] or
oxidation [57]. In those studies, the authors described impaired function-
ing of key enzymes in the cycle in models of aging-related mitochondrial
dysfunction [11,56,33]. Of lesser importance is AGE-damaging of a series
of metabolic enzymes such as transferase, implicated in ketogenesis
(hydroxymethylglutaryl-CoA synthase) and ALDH2 in detoxiﬁcation.
Thus, the majority of the glycated enzymes were identiﬁed as gener-
ally dysfunctional, losing catalytic or structural integrity [20,21,56]
and are directly or indirectly involved in critical energy metabolism
processes (fatty acid β-oxidation and the TCA cycle), leading to im-
pairment of this pathway. Current evidence suggests that reduced
capacity for fatty acid oxidation plays a role in the development of
insulin resistance that occurs with aging, an initial step in the
progression towards type 2 diabetes [58,59]. Indeed as evidenced
by the pathway analysis, most glycated enzyme networks are linked
with INSR as central node. INSR mediates the effects of insulin and
with IGF-1 both powerfully trigger the signal transduction pathway
that modiﬁes glucose and lipid metabolism, thereby inﬂuencing
cell growth, proliferation and survival [60,61]. Moreover, some
down-expressed enzymes involved in fatty acid β-oxidation, such
as long-chain speciﬁc acyl-CoA dehydrogenase, corresponded to
AGE-damaged proteins, these ﬁndings are relevant to suggest altered
mitochondrial activitywith aging. Our non-targeted and targetedprote-
omic analysis together with immunochemical ﬁndings, suggest that
signiﬁcant metabolic changes in energy production occur at an early
stage of aging (here old rats aged 20 months) in liver mitochondria,
providing valuable new information on the age-related dysfunctioning
of mitochondria.
Taken together, this study shows that the liver mitochondrial aging
is accompanied by differentially expressed enzymes mostly down
expressed, including key oxido-reductase enzymes implicated in the
fatty acid β-oxidation process, the TCA cycle and the OXPHOS complex
I/V chain. Concomitantly with this decreased expression, most of the
enzymes involved in fatty acid β-oxidation metabolism and in the
TCA/urea cycles were AGE-damaged, implying their inactivation. We
suggest that down expression of key OXPHOS complex I/V components,
in combination with AGE-damaged crucial oxido-reductase enzymes,
may be a primary determinant of the age-related decline in phospho-
oxidative capacity, leading to age-related dysfunctioning of rat liver
mitochondria.
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